📖
Prospective Study of Efficacy, Safety, and Predictors of Response to Deucravacitinib in Chinese Patients with Moderate-to-Severe Plaque Psoriasis.
Dong C, Wang Y, Sun J, Lin JM, Lu X, Zhu J, Lin L, Zhu X, Huang H, Xu J, Wu W, Du J

Prospective Study of Efficacy, Safety, and Predictors of Response to Deucravacitinib in Chinese Patients with Moderate-to-Severe Plaque Psoriasis.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Psoriasis (Auckl).

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Prospective Study of Efficacy, Safety, and Predictors of Response to Deucravacitinib in Chinese Patients with Moderate-to-Severe Plaque Psoriasis.
Author / Organization Dong C, Wang Y, Sun J, Lin JM, Lu X, Zhu J, Lin L, Zhu X, Huang H, Xu J, Wu W, Du J
Subject & Discipline Psoriasis (Auckl)
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-118649
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »